IRIS
FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.035
AS - Asia 8.635
EU - Europa 8.114
SA - Sud America 1.085
Continente sconosciuto - Info sul continente non disponibili 549
AF - Africa 134
OC - Oceania 16
Totale 35.568
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.739
SG - Singapore 3.669
IE - Irlanda 1.839
RU - Federazione Russa 1.799
CN - Cina 1.752
HK - Hong Kong 898
BR - Brasile 892
TR - Turchia 875
SE - Svezia 811
VN - Vietnam 792
DE - Germania 753
IT - Italia 705
GB - Regno Unito 572
UA - Ucraina 490
FR - Francia 377
FI - Finlandia 345
BD - Bangladesh 157
CA - Canada 150
IN - India 134
NL - Olanda 79
ES - Italia 75
JP - Giappone 74
MX - Messico 72
AR - Argentina 64
CZ - Repubblica Ceca 50
PL - Polonia 46
ZA - Sudafrica 46
BE - Belgio 44
IQ - Iraq 36
ID - Indonesia 31
CO - Colombia 30
LT - Lituania 27
PK - Pakistan 25
EC - Ecuador 24
MA - Marocco 23
AT - Austria 19
EU - Europa 18
KR - Corea 18
UZ - Uzbekistan 18
KE - Kenya 17
CL - Cile 16
PE - Perù 16
VE - Venezuela 16
JO - Giordania 15
MY - Malesia 15
AU - Australia 14
CR - Costa Rica 14
IL - Israele 14
PY - Paraguay 14
JM - Giamaica 12
TH - Thailandia 12
AZ - Azerbaigian 11
RO - Romania 11
SA - Arabia Saudita 11
HN - Honduras 10
TN - Tunisia 10
TW - Taiwan 10
PH - Filippine 9
UY - Uruguay 9
HU - Ungheria 8
LB - Libano 8
NP - Nepal 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
RS - Serbia 7
AL - Albania 5
CH - Svizzera 5
GE - Georgia 5
KG - Kirghizistan 5
SN - Senegal 5
BB - Barbados 4
DK - Danimarca 4
GT - Guatemala 4
LU - Lussemburgo 4
OM - Oman 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
EE - Estonia 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GM - Gambi 2
GR - Grecia 2
LC - Santa Lucia 2
ME - Montenegro 2
MN - Mongolia 2
Totale 34.997
Salva come PNG Salva come JPEG
Città #
Singapore 2.099
Chandler 1.944
Jacksonville 1.919
Dublin 1.835
San Jose 1.759
Dallas 1.621
Ashburn 929
Hong Kong 878
Santa Clara 865
Council Bluffs 738
Boardman 692
The Dalles 491
Izmir 425
New York 417
Moscow 353
Nanjing 338
Princeton 309
Lawrence 306
San Mateo 304
Wilmington 297
Ho Chi Minh City 250
Los Angeles 217
Lauterbourg 212
Beijing 206
Hanoi 187
Ann Arbor 156
Milan 152
Munich 123
Woodbridge 114
Nanchang 108
Columbus 103
São Paulo 99
Hefei 97
Des Moines 91
Mountain View 80
Seattle 76
Shenyang 73
Orem 71
Rome 71
Tokyo 67
Helsinki 66
Amsterdam 57
Lappeenranta 57
Tianjin 57
Hebei 55
Verona 55
Frankfurt am Main 52
L'aquila 50
Falls Church 48
Montreal 48
Brooklyn 47
London 47
Brno 45
Atlanta 43
Brussels 43
Kunming 42
Jiaxing 41
Jinan 40
Warsaw 40
Stockholm 39
Dearborn 38
Shanghai 37
Chicago 36
Denver 36
Dong Ket 35
San Francisco 35
Norwalk 34
Houston 33
Da Nang 32
Phoenix 32
Boston 31
Buffalo 29
Changsha 29
Chennai 29
Falkenstein 29
Ningbo 29
Toronto 29
Turku 28
Belo Horizonte 26
Johannesburg 25
L’Aquila 24
Manchester 24
Nuremberg 24
Mexico City 23
Zhengzhou 23
Brasília 22
Guangzhou 22
Haiphong 22
Rio de Janeiro 21
Pune 20
Ankara 19
Bremen 18
Philadelphia 18
Fremont 17
Hải Dương 17
Jakarta 17
Mumbai 17
Changchun 16
Nairobi 16
Taizhou 16
Totale 23.072
Salva come PNG Salva come JPEG
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 238
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 190
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 182
Rapid response of scalp psoriasis to ustekinumab 164
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 156
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 156
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 154
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 152
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 150
A variant in FTO shows association with melanoma risk not due to BMI 148
Staging and follow-up of cutaneous Melanoma patients 148
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 145
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 143
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 139
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 139
EDNRB gene variants and melanoma risk in two southern European populations. 138
Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients 137
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 137
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 137
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment 137
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 136
Cutaneous manifestations in Italian kidney transplant recipients 136
Early stage melanoma diagnosis and mental health-related: emotional influence of body self-perception 135
Understanding the molecular genetics of basal cell carcinoma 134
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 133
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 133
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 130
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 130
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 128
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 127
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 127
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 127
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 126
Dermoscopic features of actinic keratosis 126
On the interplay of telomeres, nevi and the risk of melanoma 126
Telomeres and telomerase in cutaneous squamous cell carcinoma 126
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 126
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 125
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 125
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients 125
Parapsoriasi 123
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 123
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 122
The spectrum of dermatoscopic patterns in blue nevi 122
Pigmented reticular structures in basal cell carcinoma and collision tumours 121
Treatments of advanced basal cell carcinoma: a review of the literature 120
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 120
Mucosal involvement in a patient with lymphomatoid papulosis 120
Early Diagnosis of Melanoma and Breast Cancer in Women: Influence of Body Image Perception 119
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 119
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations 119
Dermoscopic evolution of a congenital combined nevus in childhood 119
Molecular alterations in basal cell carcinoma subtypes 119
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 118
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 117
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 117
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 117
Pilotropic mycosis fungoides presenting as an acneiform eruption 117
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 117
Clinical experience of imiquimod 3.75% for actinic keratosis: Results from a case series 117
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 117
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 117
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts 116
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 116
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 116
Basal cell carcinoma and inflammation: role of the Gadd45b gene 116
Interferon-beta injection site reactions in patients with multiple sclerosis 116
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 116
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 116
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 116
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 115
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 115
Management of Cutaneous Squamous Cell Carcinoma of the Scalp in Kidney Transplant Recipients 114
Mycosis fungoides. Clinical and molecular biology observations 114
CONSTITUTIONAL AND ENVIROMENTAL RISK FACTORS FOR CUTANEOUS MELANOMA IN ITALIAN POPULATION. A CASE-CONTROL STUDY 114
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 114
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin 114
Clinical Trial on Aveeno Skin Relief Moisturizing Lotion in patients with itching accompanied by skin lesions and xerosis 114
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 114
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 114
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 114
T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review 113
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 113
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 113
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 113
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 113
Family history of psoriasis and age at disease onset in Italian patients with psoriasis 113
Occurrence of multiple melanomas in a patient with punctate palmoplantar keratoderma type-1A associated to alpha and gamma adaptin binding protein 112
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 112
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 112
Knowledge of melanoma and attitude towards moles in Italian melanoma 112
"Your Skin Tells You" Campaign for keratinocyte cancers: when individuals' selection makes the difference 111
Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis 111
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 111
CDKN2A/p16 expression in mycosis fungoides 111
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 111
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 110
Comprehensive Evaluation of Allele Frequency Differences of MC1R Variants Across Populations 110
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 110
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 110
Totale 12.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.598 0 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.397 210 67 147 204 88 355 42 52 1 64 31 136
2024/20256.230 165 108 590 222 734 573 902 480 1.440 200 450 366
2025/202612.781 540 1.061 1.118 1.346 1.190 783 2.381 613 1.130 1.422 956 241
2026/2027801 446 355 0 0 0 0 0 0 0 0 0 0
Totale 35.568